A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

BACKGROUND: The treatment of acute myeloid leukemia of older, medically non-fit patients still poses a highly unmet clinical need, and only few large, prospective studies have been performed in this setting. Given the established activity of hypomethylating agents such as 5-aza-2'-deoxycytidine...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lübbert, Michael, Rüter, Björn H., Claus, Rainer, Schmoor, Claudia, Schmid, Mathias, Germing, Ulrich, Kuendgen, Andrea, Rethwisch, Volker, Ganser, Arnold, Platzbecker, Uwe, Galm, Oliver, Brugger, Wolfram, Heil, Gerhard, Hackanson, Björn, Deschler, Barbara, Döhner, Konstanze, Hagemeijer, Anne, Wijermans, Pierre W., Döhner, Hartmut
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2012
Gaiak:
Original Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291594/
https://ncbi.nlm.nih.gov/pubmed/22058219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.048231
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak